Patent Assignment
Reel/Frame 067011/0648
Assignment of Assignor's Interest
Recorded: 2024-04-04
Pages: 7
Assignor
CHRISTENSEN, DALE J.
Executed: 2021-09-24
Assignee
LUNG THERAPEUTICS, INC.
3801 S. CAPITAL OF TEXAS HWY, STE 330, AUSTIN, TEXAS, 78704
Covered Property
(1)
Epithelial Sodium Channel (Enac) Inhibitor Conjugates and Methods for Use Thereof
Application:
18/577,028 →
Publication:
US US20240374585A1
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger and Change of Name
Apr 9, 2024
From: LUNG THERAPEUTICS, INC.; AT MERGER SUB II, LLC
To: LUNG THERAPEUTICS, LLC
Reel/Frame 067041/0773 →
Assignment of Assignor's Interest
Oct 7, 2024
From: CHRISTENSEN, DALE J.
To: LUNG THERAPEUTICS, LLC
Reel/Frame 068813/0398 →
Assignment of Assignor's Interest
Mar 3, 2025
From: LUNG THERAPEUTICS, LLC
To: REIN THERAPEUTICS, INC.
Reel/Frame 070384/0082 →